Correlation Between Inozyme Pharma and Voyager Therapeutics
Can any of the company-specific risk be diversified away by investing in both Inozyme Pharma and Voyager Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inozyme Pharma and Voyager Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inozyme Pharma and Voyager Therapeutics, you can compare the effects of market volatilities on Inozyme Pharma and Voyager Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inozyme Pharma with a short position of Voyager Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inozyme Pharma and Voyager Therapeutics.
Diversification Opportunities for Inozyme Pharma and Voyager Therapeutics
0.31 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Inozyme and Voyager is 0.31. Overlapping area represents the amount of risk that can be diversified away by holding Inozyme Pharma and Voyager Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Voyager Therapeutics and Inozyme Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inozyme Pharma are associated (or correlated) with Voyager Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Voyager Therapeutics has no effect on the direction of Inozyme Pharma i.e., Inozyme Pharma and Voyager Therapeutics go up and down completely randomly.
Pair Corralation between Inozyme Pharma and Voyager Therapeutics
Given the investment horizon of 90 days Inozyme Pharma is expected to under-perform the Voyager Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Inozyme Pharma is 1.07 times less risky than Voyager Therapeutics. The stock trades about -0.73 of its potential returns per unit of risk. The Voyager Therapeutics is currently generating about -0.22 of returns per unit of risk over similar time horizon. If you would invest 702.00 in Voyager Therapeutics on August 28, 2024 and sell it today you would lose (127.00) from holding Voyager Therapeutics or give up 18.09% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Inozyme Pharma vs. Voyager Therapeutics
Performance |
| Timeline |
| Inozyme Pharma |
| Voyager Therapeutics |
Inozyme Pharma and Voyager Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Inozyme Pharma and Voyager Therapeutics
The main advantage of trading using opposite Inozyme Pharma and Voyager Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inozyme Pharma position performs unexpectedly, Voyager Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Voyager Therapeutics will offset losses from the drop in Voyager Therapeutics' long position.| Inozyme Pharma vs. Eliem Therapeutics | Inozyme Pharma vs. HCW Biologics | Inozyme Pharma vs. Scpharmaceuticals | Inozyme Pharma vs. Milestone Pharmaceuticals |
| Voyager Therapeutics vs. Day One Biopharmaceuticals | Voyager Therapeutics vs. X4 Pharmaceuticals | Voyager Therapeutics vs. Inozyme Pharma | Voyager Therapeutics vs. Acumen Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Other Complementary Tools
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |